Crestview Capital to Lead $11-15 Million Funding Round for bioMETRX

Crestview Capital Partners, the majority owner of Biometric Investors, LLC, has agreed to lead bioMETRX's next funding round, which is expected to total between $11.0 and $15.0 million, including the contribution of assets valued over $5 million.

“Crestview has agreed to take the lead in bioMETRX’s next round of funding that is expected to total between $11.0 and $15.0 million, including the contribution of assets valued in excess of $5 million dollars”

Signals are extracted from public coverage and print archives and pinned to a verbatim quote, presented as reported by their sources; naming a company in a signal is not an accusation against it. The verified mark denotes a high-confidence, corroborated signal. See our methodology and legal notes.